iRhythm Holdings, Inc. Defined Contribution Plan, Employer Matching Contribution, Percent of Match
iRhythm Holdings, Inc. (IRTC) reported Defined Contribution Plan, Employer Matching Contribution, Percent of Match of 50.00% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Notes › Compensation Related Costs › Defined Contribution Plan
us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch · last filed 2026-02-19
- iRhythm Holdings, Inc. defined contribution plan, employer matching contribution, percent of match for fiscal 2025 was 50.00%, a 0.00% change from fiscal 2024.
- iRhythm Holdings, Inc. defined contribution plan, employer matching contribution, percent of match for fiscal 2024 was 50.00%, a 0.00% change from fiscal 2023.
- iRhythm Holdings, Inc. defined contribution plan, employer matching contribution, percent of match for fiscal 2023 was 50.00%, a 0.00% change from fiscal 2022.
- iRhythm Holdings, Inc. defined contribution plan, employer matching contribution, percent of match for fiscal 2022 was 50.00%.
| Period end | Defined Contribution Plan, Employer Matching Contribution, Percent of Match 12 month |
|---|---|
| 2025-12-31 | 50.00% 10-K · filed 2026-02-19 |
| 2024-12-31 | 50.00% 10-K · filed 2025-02-20 |
| 2023-12-31 | 50.00% 10-K · filed 2024-02-22 |
| 2022-12-31 | 50.00% 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |